Event Highlights Progress on Brain Disease Research...
Researchers from the MassGeneral Institute for Neurodegenerative Diseases (MIND) detailed some of the latest advances in brain disease research at MIND’s 2018 Visiting Day.
Stroke Patient Says “Amazing Staff” Saved His Life...
A grateful stroke patient from Methuen, Massachusetts says the swift work of his expert Mass General care team allowed him to return home to enjoy his family, including a new granddaughter.
ALS: Rare Form of Disease Studied for Clues...
A Mass General researcher is studying a rare, inherited form of ALS, aiming to diagnose the disease in its earliest stages and develop new treatments.
Multiple Sclerosis Care Advances but Work Remains...
A clinician-investigator from Mass General’s Multiple Sclerosis Clinic discusses treatment options for MS patients and how research could help in diagnosing and monitoring the disease.
Neurofibromatosis Research Reflects Clinic-Lab Link...
At Mass General, Scott Plotkin, MD, PhD, and Vijaya Ramesh, PhD, are using their respective expertise in clinical and fundamental science to investigate new treatments for neurofibromatosis and two related disorders.
Philanthropy Fuels Movement Disorder Breakthrough...
Donor commitment allows rare disease research breakthrough, providing insights into Parkinson’s and other movement disorder diseases.
Rare Diseases: Collaboration Key to Mass General Advances...
Genetic insights into rare diseases and new models of collaborative research that involve patients, clinicians, scientists and members of industry could produce much-needed new treatments.
Migraine: Research Model Aims to Predict Attacks...
Mass General researchers have developed a forecasting model for predicting future migraine attacks based on current levels of stress and head pain.
Revealing the Brain’s Secrets...
Invented at Mass General, a technology called fMRI continues to have a revolutionary impact on brain science and patient care.
ALS House Call Program Sets New Care Standard...
Mass General ALS experts believe the new ALS House Call Program will help to change the course of medical care planning and improve outcomes for people with amyotrophic lateral sclerosis.